Pleural Complications in Patients with Renal Cell Carcinoma Undergoing Percutaneous Cryoablation: A Retrospective Analysis of its Incidence and Risk Factors.
Percutaneous Cryoablation
Pleural Complication
Pleural Effusion
Pneumothorax
Renal Cell Carcinoma
Journal
The American journal of the medical sciences
ISSN: 1538-2990
Titre abrégé: Am J Med Sci
Pays: United States
ID NLM: 0370506
Informations de publication
Date de publication:
16 Sep 2024
16 Sep 2024
Historique:
received:
08
04
2024
revised:
09
09
2024
accepted:
09
09
2024
medline:
19
9
2024
pubmed:
19
9
2024
entrez:
18
9
2024
Statut:
aheadofprint
Résumé
Observations from our clinical practice indicate a notable occurrence of pleural complications post-percutaneous renal cryoablation (PRC). To identify the incidence of pleural complications following PRC and potential risk factors associated with post-procedural pleural complications. This was a retrospective cohort analysis of patients undergoing PRC at two tertiary hospital systems between 2016 and 2022. Patient characteristics, radiological and clinical data, and procedure techniques were collected in a database to identify potential risk factors. A total of 285 patients were identified who underwent 312 PRC procedures during the specified inclusion period. Among these, 10 procedures (3.2%) led to pleural complications, all manifesting as pleural effusions. Of these complications, 3 patients (1%) required pleural drainage. Factors associated with an increased risk of pleural complications included a larger mean tumor size (4.3 cm vs 2.7 cm, P = <0.001), cryoprobe applicator entry at the T10-T11 level as opposed to lower sites (P = 0.029), and a higher median number of cryoprobe applicators employed (3.5 vs 2.0, P = 0.001). Moreover, individuals who experienced pleural complications had a longer median hospital stay (4.0 vs 0, P≤0.001) and a higher rate of blood transfusions (40% vs 0.7%, P≤0.001). Pleural complications from percutaneous renal cryoablation are rare. To further reduce the risk, higher insertion points (above T12) and utilizing more than two cryoprobe applicators should be avoided when feasible. Pleural complications in patients with new respiratory symptoms after PRC should be considered.
Identifiants
pubmed: 39293739
pii: S0002-9629(24)01447-2
doi: 10.1016/j.amjms.2024.09.003
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of competing interest Gary Siskin is a consultant for Boston Scientific. None of the authors has any conflict of interest regarding this manuscript.